Silver Marketing Association Webinar: Understanding the Older Traveller – Research and Insights from Industry Experts

GCOA Executive Director Melissa Gong Mitchell was featured in a webinar with the Silver Marketing Association addressing the unique preferences and needs of older travelers and how to capture the benefits of the silver economy in the travel sector. The expert speakers showcased three ground-breaking pieces of original research which decode the 50+ travel market.

Watch the webinar here.

Moderated by Debbie Marshall, Managing Director of the Silver Marketing Association, the speakers included:

  • Jasman Ahmad –  Don’t Call Me Old! – this white paper challenges the conventional approach, offering a fresh perspective by examining these travellers’ unique motivations, psychologies, and preferences.
  • Carolyn Ray – Invisible No More: The Ageless Adventuress – this study is the most in-depth of its kind. Over 1,630 women share their travel preferences, spending, preferred destinations, purchasing habits and more.
  • Melissa Mitchell  – Leveraging Travel as a Catalyst for Healthy Longevity –  this report amplifies the relationship between travel and healthy aging and underscores the value it brings to the economy, workplace productivity and well-being, and retirement.

Jasman Ahmad, Strategy Director at Accord Marketing  

Having worked in various account management roles since joining Accord in 2006, Jasman was appointed Strategy Director in 2018 and to the Accord Board in April 2024.

Jasman is a dynamic marketing professional who is passionate about connecting with the over-50s demographic. With a deep understanding of this group’s complexity and diversity, he is driven by a mission to challenge outdated stereotypes and craft campaigns that reflect authenticity, inspire loyalty, and drive meaningful engagement.

Research is Jasman’s superpower. Utilising specialist media tools to undertake market research and audience analysis, his approach is rooted in empathy and insight – delving into the values, interests, lifestyles and aspirations that define this audience to uncover buying habits, expose brand loyalties, and identify growth opportunities.

 

Carolyn Ray, CEO at JourneyWoman  

As the CEO and Editor of JourneyWoman, Carolyn is a passionate advocate for women’s travel and living the life of your dreams. She leads JourneyWoman’s team of writers and chairs the JourneyWoman Women’s Advisory Council and Women’s Speaker’s Bureau. In 2023, she was named one of the most influential women in travel by TravelPulse and is the recipient of two SATW travel writing awards, most recently in May 2025. She published her first book “Never Too Late: How Women 50+ Travellers Are Making the Rules” in 2025, with co-author Lola Akinmade.

Carolyn has been featured in the New York Times, Skift, The Toronto Star and Conde Nast as a solo travel expert, and speaks at women’s travel conferences around the world. She is the chair of the Canadian chapter of the Society of American Travel Writers (SATW), a member of Women Travel Leaders and a Herald for the Transformational Travel Council (TTC). Named a top 100 Female Entrepreneurs in Canada in 2012; she’s also a Co-Active Life Coach and proud mom of Alyxandra. Sometimes she sleeps. A bit.

 

Melissa Mitchell, Executive Director,  Global Coalition on Aging

Melissa Gong Mitchell is Executive Director of the Global Coalition on Aging (GCOA), the leading business voice on ageing policy and strategy, and Senior Managing Director at High Lantern Group, a strategic communications consultancy. At GCOA, she oversees operations, advocacy, communications and member engagement, bringing together corporations across industries to drive healthy ageing, policy innovation and growth in the silver economy.

With over 20 years’ experience in public affairs, Melissa is a recognised speaker on the ageing mega-trend and the role of business in leveraging longevity for economic growth. She has served on boards and working groups including Champions of Aging, Age-friendly New York City and the Skin Cancer Foundation.

Previously, she was Director of Industry Relations at the U.S. Travel Association, leading campaigns that influenced positive legislative outcomes, and Executive Director of the Travel Business Roundtable. She began her career at Prime Policy Group, a Washington-based government affairs firm.

Melissa holds an MBA from Georgetown University and a BA in Journalism and Psychology from the University of Mississippi.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.